Join SGO for a 75-minute webinar where chemotherapy and clinical trial leaders from across the U.S. discuss perspectives on chemotherapy considerations for upfront, maintenance, and recurrent ovarian cancer patients, chemotherapy considerations for endometrial cancer patients given increased co-morbidities, infusion considerations for elderly patients, and clinical trial challenges (new trials, new enrollment, patients on treatment, and in follow-up) during the COVID-19 crisis.

This webinar was recorded on March 31, 2020. 

This content is not eligible for CE. 

SGO thanks AstraZeneca, Eisai, Genentech, and Merck for their sponsorship of our COVID-19 Resources.

Keywords: Chemotherapy, Clinical trial, COVID